Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -454 | -1,264 | -975 | -694 | -322 |
| Depreciation Amortization | 29 | 206 | 195 | 149 | 71 |
| Accounts receivable | -13 | -26 | 10 | 1 | 28 |
| Other Working Capital | 163 | 310 | 264 | 178 | 121 |
| Other Operating Activity | 154 | 460 | 336 | 242 | 42 |
| Operating Cash Flow | $-120 | $-315 | $-170 | $-124 | $-59 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -17 | -15 | -14 | -2 |
| Purchase Sale Intangibles | -11 | -46 | -57 | -51 | -33 |
| Other Investing Activity | -11 | -46 | -57 | -51 | -33 |
| Investing Cash Flow | $-42 | $-63 | $-72 | $-65 | $-35 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 13 | 25 | 38 | N/A |
| Common Stock Issued | 187 | 327 | 212 | 159 | 95 |
| Other Financing Activity | -5 | 34 | 3 | -8 | -9 |
| Financing Cash Flow | $182 | $374 | $240 | $190 | $86 |
| Beginning Cash Position | 13 | 17 | 17 | 17 | 17 |
| End Cash Position | 33 | 13 | 15 | 18 | 8 |
| Net Cash Flow | $20 | $-4 | $-2 | $1 | $-9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120 | -315 | -170 | -124 | -59 |
| Capital Expenditure | -31 | -17 | -15 | -14 | -2 |
| Free Cash Flow | -151 | -332 | -185 | -138 | -61 |